Search results
NetEase maintains shares target on new Match-3 mobile game approval By Investing.com
Investing.com· 7 hours agoThe firm’s latest commentary highlights the approval of a game license for NetEase's new Match-3...
Amgen's (AMGN) Tarlatamab Receives FDA Approval for SCLC
Zacks via Yahoo Finance· 3 days agoDLL3 is a protein that is expressed on the surface of SCLC cells in most patients. The approval was...
China’s NMPA approves Zai Lab’s XACDURO NDA for pneumonia
Pharmaceutical Technology via Yahoo Finance· 13 hours agoZai Lab and Innoviva Specialty Therapeutics have announced the approval of China’s National Medical...
PTC Therapeutics stock target raised on re-evaluation of Translarna By Investing.com
Investing.com· 7 hours agoThe analyst drew a parallel with the case of Glybera, which received official approval from the...
JPMorgan maintains overweight rating on Dynatrace with $60 target By Investing.com
Investing.com· 7 hours agoOn Monday, JPMorgan (NYSE:JPM) reiterated its Overweight rating with a $60.00 price target for...
Iowa universities set highest dorm rate hikes in years
Waterloo-Cedar Falls Courier· 14 hours ago“Resulting from inflationary pressures on utilities, wages and nondurable goods, the rate increase...
Canaccord maintains target on Inventiva shares amid MASH therapy potential By Investing.com
Investing.com· 13 hours agoThe firm's optimism is rooted in the potential of Inventiva's drug candidate lanifibranor,...
Positive trial outcomes lead BMO to maintain outperform rating on Gilead stock By Investing.com
Investing.com· 13 hours agoThe data suggests potential approval and use of seladelpar in combination with Ursodeoxycholic Acid...
The Worst Best Economy Ever
The Atlantic· 11 hours agoJoe Biden is, at the moment, losing his reelection campaign. The jobless rate is below 4 percent, as it has been for nearly two and a half years. Wage growth is moderating ...
When the yield curve offers no guidance, what is an investor to do? | Cumberland Comment
Herald-Tribune via Yahoo Finance· 13 hours agoBiden’s approval rating is 35%. Trump’s personal favorability is 33%. Two head-to-head numbers:...
